Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CASI Pharmaceuticals, Inc. | Chairman and CEO, Director, 10%+ Owner | Common Stock | 645K | Jun 15, 2022 | Direct | ||
CASI Pharmaceuticals, Inc. | Chairman and CEO, Director, 10%+ Owner | Common Stock | 44.1K | Jun 13, 2022 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CASI | CASI Pharmaceuticals, Inc. | Jun 13, 2022 | 3 | $273K | 4 | Jun 17, 2022 | Chairman and CEO, Director, 10%+ Owner |
CASI | CASI Pharmaceuticals, Inc. | Nov 17, 2021 | 2 | $394K | 4 | Nov 19, 2021 | Chairman and CEO, Director |
CASI | CASI Pharmaceuticals, Inc. | Aug 18, 2021 | 2 | $614K | 4 | Aug 20, 2021 | Chairman and CEO, Director |
CASI | CASI Pharmaceuticals, Inc. | Jun 15, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Chairman and CEO, Director, 10%+ Owner |